Home » Products » Gefitinib Tablets 250mg | GMP Manufacturer & Supplier | Sinophare
Product Description
| Product Name | Gefitinib Tablets (Gefitinib 250mg Oral Tablets) |
| Specification | Each tablet contains: Gefitinib 250mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Gefitinib |
| Pharmacological Class | Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (Targeted Therapy) |
| Route of Administration | Oral administration (swallowed whole with water; may be taken with or without food). Take at approximately the same time each day. |
| Packaging | Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 36 months (unopened) |
Product Overview
Gefitinib Tablets is an oral preparation containing Gefitinib 250mg per film-coated tablet. Gefitinib is a targeted therapy agent that selectively inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used for the treatment of specific types of non-small cell lung cancer (NSCLC) in patients with EGFR mutations. The product is formulated as film-coated tablets for oral administration, providing a convenient and accurate dosing form for long-term oral therapy.
